(Date:9/5/2008)...n Humane Shows Public Reluctant to Evacuate, Witho...on Efforts Confirm Sur...07 survey by the American Humane,Association found...assistance if it meant leaving without their famil...ving towards the U.S. coast, residents and,officia...
(Date:9/5/2008)...swire-USNewswire/ -- Speaker Nancy Pelosi,issued t...s of the "Stand,Up to Cancer" telethon, to be aire...n in our country who has not seen a loved one,suff...ns annually, and each,year there are more than 1.4...er to make eradicating the scourge of cancer a nat...
(Date:9/5/2008)...re/ -- EthicAd, a nonprofit organization,devoted t...on, announces,the launch of a new FDA Web site cre...direct-to-consumer (DTC) advertising of prescripti...tion Drug Advertising," is,hosted by the FDA,s Cen...oped by the FDA in partnership with EthicAd. For d...
(Date:9/5/2008)...mone-receptor positive, metastatic breast cancer m...ancer at bay, but when the tumor becomes resistant...py becomes the only option. But a study presented ...change this approach. Early data suggests a new t...lowing anti-hormonal drugs to do their job once ag...
Breaking Medicine News(10 mins):Health News:Nearly Half of Americans Won't Flee Without Fido 2Health News:Nearly Half of Americans Won't Flee Without Fido 3Health News:Nearly Half of Americans Won't Flee Without Fido 4Health News:Prescription Drug Advertising Subject of New FDA Web Site for Consumers 2Health News:1 step back ... 2 steps forward 2(Date:9/5/2008)...ates microRNAs Extracted From a Simple Blood Draw ...Biomarkers for a Wide Range of ...ology, Rosetta Genomics is Currently Developing ...cer, REHOVOT, Israel and JERSEY CITY, New Jersey,...omics, Ltd. (NASDQ: ROSG), a leader in,the develop...
(Date:9/4/2008)...., Sept. 4 /- BioForm Medic... pivotal clinical study of,Polidocanol, conducted ...,Fabrik KREUSSLER & Co. GmbH (Kreussler), successf...ubmitted to FDA as part of a New Drug Application,...med the EASI (Efficacy and safety of,Aethoxysklero...
(Date:9/4/2008)...n for Obstetrician-Gynecologists States UFE Meets ...mally Invasive Interventional,Radiology Treatment ...ibroids, FAIRFAX, Va., Sept. 4 /PRNewswire-USNews...a national organization of nearly 4,500 doctors,s...d to improving health,care through minimally invas...
(Date:9/4/2008)...and, September 4 /- Axentis Pharma AG...s the safety and tolerability,of a new therapeutic...,infection in cystic fibrosis patients. The new fo...to be delivered directly to the site of,infection....ts of two,different doses of the new drug. Initial...
Breaking Medicine Technology:Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 2338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 3338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 4338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment 5Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4UF researchers develop improved gene therapy agent 3363 1UF researchers develop improved gene therapy agent 3363 2UF researchers develop improved gene therapy agent 3363 3MR imaging accurately determines prostate cancer treatment failure 19783 1Abnormal editing of gene messages may be a cause of lupus 19779 1Abnormal editing of gene messages may be a cause of lupus 19779 2Pivotal Study Shows Physician Nurse Teams Using SEDASYS 28TM 29 System Reduced Risk of Over Sedation With Propofol 2121 1Pivotal Study Shows Physician Nurse Teams Using SEDASYS 28TM 29 System Reduced Risk of Over Sedation With Propofol 2121 2Pivotal Study Shows Physician Nurse Teams Using SEDASYS 28TM 29 System Reduced Risk of Over Sedation With Propofol 2121 3Pivotal Study Shows Physician Nurse Teams Using SEDASYS 28TM 29 System Reduced Risk of Over Sedation With Propofol 2121 4...l 20,2007-The U.S. Food and Drug,Administration (F...umers to the availability of audio broadcasts that...adcasts, commonly known as,podcasts, can be transm...yers. , The service is part of the agency,s ongoin...concerning the safety of,marketed medications when...
...l 18, 2007--Due to water damage caused by,flooding...he,location for the upcoming Antiviral Drugs Advis... new drug application for,maraviroc 300 milligram ...A, Center for Drug Evaluation and Research Advisor...ne, in Rockville, MD, the,meeting has been relocat...
Other Medicine Technology:FDA Announces Audio Broadcasts on Emerging Drug Safety Information 2FDA Announces Change of Location Notice for Upcoming Advisory,Committee Meeting 2...eel-away introducers. Our peel-away introducers ar...rillator lead implantation, central venous cathete...er insertions. The advanced design of St. Jude Med...ade; locking dilator and offers the same insertion...
The RX HERCULINK® PLUS Biliary Stent System is Guidant's high performance .014" guide wire compatible system. It is available in stent diameters of 4.0-6.5mm for the 12mm stent length and 4.0-7.0
Supreme and Response catheters comprise the world's broadest line of fixed-curve catheters available for electrophysiology procedures. Their advanced catheter design and materials technology provide
Supreme and Response catheters comprise the world's broadest line of fixed-curve catheters available for electrophysiology procedures. Their advanced catheter design and materials technology provide
Medicine Products: